Contracts for Innovation: industrial human-relevant drug models

Who can apply

Your project

Projects must:

• start by 1 July 2026

• end by 31 March 2027

• last between six and nine months

• have total costs of no more than £200,000, inclusive of VAT

Projects must always start on the first of the month, even if this is a non-working day. You must not start your project until your Contract has been approved by Innovate UK.

You must only include eligible project costs in your application. See our overview of eligible project costs. For specific guidance, see the eligibility section in this competition.

If your project’s total costs or duration falls outside of our eligibility criteria, you must provide justification by email to support@iuk.ukri.org at least 10 working days before the competition closes. We will decide whether to approve your request.

If you have not requested approval or your application has not been approved by us, you will be made ineligible. Your application will then not be sent for assessment.

Innovate UK, as part of UKRI, will share the application, and any personal information that it contains, with our delivery partner NC3Rs. They are participating in the assessment process. For information about how IUK and NC3Rs handle personal data, read UKRI’s privacy notice.

Applicant

To lead a project, you can:

• be an organisation of any size, including those based in the EU, EEA or internationally

• work alone or with the subcontracted skills and expertise of others from business, research organisations, research and technology organisations, or the third sector (charities, social enterprises and voluntary groups)

Contracts will be awarded to a single legal entity only. The majority of the project work and key deliverables must be completed by the applicant and be carried out in the UK. Subcontractors can be used, but only for specialist skills.

Sanctions

This competition will not fund you, or provide any financial benefit to any individual or entities directly or indirectly involved with you, which would expose Innovate UK or any direct or indirect beneficiary of funding from Innovate UK to UK Sanctions. For example, through any procurement, commercial, business development or supply chain activity with any entity as lead, partner or subcontractor related to these countries, administrations and terrorist groups.

Use of animals in research and innovation

Innovate UK expects and supports the provision and safeguarding of welfare standards for animals used in research and innovation, according to best practice and up to date guidance.

Applicants must ensure that all of the proposed work within projects, both that in the UK and internationally, will comply with the UKRI guidance on the use of animals in research and innovation.

Any projects selected for funding which involve animals will be asked to provide additional information on welfare and ethical considerations, as well as compliance with any relevant legislation as part of the project start-up process. This information will be reviewed before an award is made.

Funding

Up to £2 million, inclusive of VAT has been allocated to fund innovation projects in this phase 1 feasibility study research and development (R&D) competition. Contracts will be up to £200,000, inclusive of VAT, for each project for up to nine months. We expect to fund up to 12 projects.

This is subject to us receiving a sufficient number of high quality applications. Funding will be in the form of a contract.

We reserve the right to adjust funding allocations for any of our competitions under exceptional circumstances for example, in response to changes in policy, portfolio funding considerations, or broader government funding decisions.

Up to £6 million, inclusive of VAT, is expected to be allocated to a potential phase 2. Phase 2 contracts of up to £1.5 million, inclusive of VAT may be awarded to further develop your technology. It may also include undertaking the necessary evaluations for demonstrating the feasibility of your product in real world commercial drug development context for up to 24 months.

The total funding available for the competition can change. The funders have the right to:

• redefine the funding

• adjust the provisional funding allocations between the phases

• apply a ‘portfolio’ approach

• in exceptional circumstances withdraw the funding, redefine the individual funding awards or terminate projects before the planned end date

Value Added Tax (VAT)

You must select whether you are VAT registered before entering your eligible project costs.

VAT is the responsibility of the invoicing business. We will not provide any further advice and suggest you seek independent advice from HMRC.

VAT registered

If you select you are VAT registered, you must enter your eligible project costs exclusive of VAT. As part of the application process VAT will be automatically calculated and added to your project cost total. Your total eligible project costs inclusive of VAT must not exceed £200,000.

Not VAT registered

If you select you are not VAT registered, you must enter your eligible project costs exclusive of VAT and no VAT will be added. You will not be able to increase total project costs to cover VAT later should you become VAT registered. Your total project costs must not exceed £200,000.

Research and development (R&D)

Your application must have at least 50% of the contract value attributed directly and exclusively to R&D services, including solution exploration and design. R&D can also include prototyping and field-testing the product or service. This lets you incorporate the results of your exploration and design and demonstrate that you can produce in quantity to acceptable quality standards.

R&D does not include:

• commercial development activities such as quantity production

• supply to establish commercial viability or to recover R&D costs

• integration, customisation or incremental adaptations and improvements to existing products or processes

Innovate UK may revoke our decision to provide funding without notice if government commitment for this initiative is withdrawn.

Subsidy control

Contracts for Innovation competitions involve procurement of R&D services and are not subject to subsidy control criteria. This competition is run by the Authority under the Procurement Act 2023 (R&D exemption).

Your project

The aim of this competition is to support organisations developing disruptive and innovative alternatives for improved pharmacokinetic (PK) and cardiac safety studies to:

• further qualify the methods towards broad adoption

• or improve their applicability in a drug development setting

Your project must focus on developing new approaches or further developing existing approaches that can be deployed within a drug development setting. It must enable progress towards the government targets of:

• more than 35% reduction in dedicated PK studies using dogs or non-human primates (NHPs)

• more than 50% reduction in dedicated cardiovascular safety studies using dogs or NHPs by 2030

This is a two phase competition, with contracts awarded only for Phase 1. You must define your goals in your application and an outline of your plan for phase 2.

Phase 1 must demonstrate how the proposed work will establish feasibility and lay the groundwork for achieving these outcomes in Phase 2.

Ultimately, your project is expected to deliver a model that aims to meet the accuracy, cost and throughput requirements to credibly replace equivalent in vivo models.

You must demonstrate a practical and credible route to market supported by a clear commercialisation plan and include plans to achieve regulatory engagement where required.

You must intend to exploit the primary outputs of these projects in the UK.

This competition supports the delivery of the UK Government’s Replacing animals in science strategy.

In this competition we want to fund a variety of projects across different technologies, technological maturities, theme and location. We call this a portfolio approach.

Specific themes

Your project can focus on, but is not limited to, one or more of the following:

Pharmacokinetic studies

• improving the predictive capacity of artificial intelligence or machine learning (AI or ML) assisted pharmacokinetic (PK) and pharmacodynamic (PD) prediction models

• increasing the exposure capabilities of in vitro models for the generation of PK or PD data

• improved and increased use of existing PK or PD data to better inform modelling approaches and increase their scope

• demonstrating combinatorial in vitro or in silico approaches to reduce the numbers of animals used in dedicated PK studies

Cardiovascular Safety

• improve the robustness and reproducibility of existing in vitro assays in the generation of cardiovascular (CV) safety data

• improve the predictive capacity of in silico cardiac safety models

• improve the accuracy, reliability of combinatorial in silico and in vitro cardiovascular safety assays

• address current unmet needs in cardiovascular safety with the novel generation or application of alternative approaches

• demonstrate the integration of alternatives into a standardised framework for cardiovascular safety that can be readily deployed across industry R&D

• the focus can be on early screening or in-depth mechanistic toxicity studies

Research categories

Phase 1: technical feasibility studies

This means planned research or critical investigation to gain new knowledge and skills for developing new products, processes or services. For applicants with an existing asset this may include establishing the feasibility of integrating their asset into the regulatory pathway for drug development or of scaling their asset to a competitive level of throughput and cost.

Phase 2: prototype development and evaluation

This can include prototyping, demonstrating, piloting, testing and validation of new or improved products, processes or services in environments representative of real-life operating conditions. The primary objective is to make further technical improvements on products, processes or services that are not substantially set.

Projects we will not fund

We will not fund projects that:

• are not original in scope and duplicates someone else’s work

• generate novel in vivo data, for example, from rodents, minipigs and non-human primates, during phase 1

• focus solely on the refinement of in vivo models

• do not intend to exploit primary outputs in the UK

• would directly duplicate other UK Government or EU funded initiatives you have already been funded to deliver

• are covered by existing commercial agreements to deliver the proposed solutions

4 March 2026

Online briefing event: register to attend

Briefing slides will be available to download from supporting information after the event

10 March 2026

NC3Rs workshop: register to attend

19 May 2026

Applicants notified

19 May 2026

Feedback

30 June 2026

Contracts awarded

1 July 2026

Project start from

Before you start

By submitting an application, you agree to the terms of the draft contract which is available once you start your application. The terms of the contract are non-negotiable and are included in the draft contract. We reserve the right to change the terms and conditions if necessary.

The final contract will include any milestones you have agreed with the funding authority and will be sent to you if your application is successful. The contract is binding once it is returned by you and signed by both parties.

When you start an application, you will be prompted to create an account as the lead applicant or sign in as a representative of your organisation. Using your account, you will be able to track your applications progress.

As the applicant you are responsible for:

• collecting the information for your application

• representing your organisation in leading the project if your application is successful

You will be able to invite colleagues from your organisation to contribute to the application.

What happens next

A selected panel of assessors will review and score your application. You will be notified of the outcome and feedback will be provided. Contracts for this phase 1 will then be issued to all successful applicants.

What we will ask you

The application is split into four sections:

1. Project details.

2. Application questions.

3. Finances.

4. Project Impact.

You must read the guidance on applying for a competition on the Innovation Funding Service before you start.

Before submitting, it is the lead applicant’s responsibility to make sure:

• that all the information provided in the application is correct

• your proposal meets the eligibility and scope criteria

• all sections of the application are marked as complete

You can reopen your application once submitted, up until the competition deadline. You must resubmit the application before the competition deadline.

Accessibility and Inclusion

We welcome and encourage applications from people of all backgrounds and are committed to making our application process accessible to everyone. This includes making reasonable adjustments, for people who have a disability or a long-term condition and face barriers applying to us.

You can contact us at any time to ask for guidance.

We recommend you contact us at least 15 working days before this competition’s closing date to allow us to put the most suitable support in place. The support we can provide may be limited if you contact us close to the competition deadline.

You can contact Innovate UK by email or call 0300 321 4357. Our phone lines are open from 9am to 12pm and 2pm to 5pm UK time, Monday to Friday (excluding bank holidays).

1. Project details

This section provides background for your application and is not scored.

Application details

Give your project’s title, start date and duration.

Who made you aware of the competition?

Select a category to state who made you aware of the competition. You cannot choose more than one.

How long has your organisation been established for?

Select a category to state how long has your organisation been established for. You cannot choose more than one.

What is your organisation’s primary focus area?

Select a category to state your organisation’s primary focus area. You cannot choose more than one.

Project and scope summary

Provide a short summary of your project.

Describe your project briefly. Be clear about what makes it innovative and how it relates to the scope of the competition. How does it tackle different aspects of the challenge and how will it provide an integrated solution?

Give details of the lead organisation. Before you submit, we expect you to have discussed your application within your organisation.

Your answer for this section can be up to 800 words long.

This section is not scored, but we will use it to decide whether the project fits the scope of the competition. If it does not, it may be rejected.

Public description

Provide a brief description of your project. If your application is successful, we will publish this description. This can happen before you start your project. This question is mandatory, but we will not assess this content as part of your application.

Describe your project in a way that you are happy to see published. Do not include any commercially sensitive information. We have the right to amend the description before publication if necessary but will consult you about any changes.

Your answer can be up to 400 words long.

Applicant location

You must state the name of your organisation along with your full registered address.

You must also state the name and full registered address of any potential or confirmed subcontractors.

We are collecting this information to understand the geographical location of all participants of a project.

Your answer can be up to 400 words long.

2. Application questions

The assessors will score all of your questions except questions 1 to 6 which are not scored. You will receive feedback for each scored question. Find out more about how our assessors assess and how we select applications for funding.

Your answer to each question can be up to 400 words long. Do not include any URLs in your answers unless we have explicitly requested a link to a video. If you do, your application will be made ineligible.

Question 1. Themes (not scored)

Select one main theme from the specific themes list in the ‘Scope’ section of this competition. You cannot choose more than one.

The themes are:

• Pharmacokinetic studies

• Cardiovascular Safety

Question 2. Animal testing (not scored)

Will your project involve any trials with animals or animal testing?

You must select one option:

• Yes

• No

We will only support innovation projects conducted to the highest standards of animal welfare.

Further information for proposals involving animal testing is available at the UKRI Good Research Hub and NC3R’s animal welfare guidance.

Question 3. Permits and licences (not scored)

Will you have the correct permits and licences in place to carry out your project?

We are unable to fund projects which do not have the correct permits or licences in place by your project start date.

You must select one option:

• Yes

• No

• In the process of being applied for

• Not applicable

Question 4. International collaboration (not scored)

Does your proposed work involve any international collaboration or engagement?

You must provide details of any expected international collaboration or engagement.

You must include a list of the names and the countries, any international project co-leads, project partners, visiting researchers, or other collaborators are based in.

You must also include details of any subcontractors or service providers.

If your proposed work does not involve international collaboration or engagement, your answer must confirm this.

Question 5. Export licence (not scored)

You must indicate whether an export control license is required for this project under the academic export control guidance.

You must select one option:

• Yes

• No

Question 6. Trusted Research and Innovation (not scored)

You must explain if your proposed project work relates to UKRI’s Trusted Research and Innovation (TR&I) Principles, including:

• a list of any dual-use (both military and non-military) applications to your research

• a list of the areas where your project is relevant to one or more of the 17 areas of the UK National Security and Investment (NSI) Act

• whether an export control license is required for this project under the academic export control guidance and the status of any applications

• a list of any items or substances on the UK Strategic Export Control List

If your proposed work does not relate to UKRI’s TR&I Principles, your answer must confirm this.

We may ask you to provide additional TR&I information at a later date, in line with UKRI TR&I Principles and funding terms and conditions.

Question 7. Proposed idea or technology

How does the project meet the challenge described in the competition scope?

Describe how the project will help deliver the government’s targets for Pharmacokinetic (PK) and Cardiovascular Safety (CV) safety testing. Include a summary of the in vivo studies that the proposed alternative methods will replace, specifying the species and approximate numbers of animals currently used.

Provide a description of your proposed idea or technology.

Include a description of the current state of development or readiness of the idea.

You can submit a single appendix as a PDF containing images and diagrams to support your answer. It must be a PDF no larger than 10MB. It can be up to two A4 pages and must be legible at 100% zoom.

This question will be scored against this assessment criterion: How well does the proposal meet the challenge?

Question 8. Technical project summary

What are the main technical challenges you are addressing?

Explain:

• how you will address the challenge

• what the innovation is

• the main technical deliverables

• the research and development that will prove the scientific, environmental and commercial merit of the project

• what might be achieved by deploying the innovation to address the selected challenge

This question will be scored against this assessment criterion: How valid is the technical approach?

Question 9. Current state of the art and intellectual property

Are similar products currently available in the market?

How is your proposed project differentiated from them?

You must include details of:

• any existing intellectual property (IP)

• its significance to your freedom to operate

• novel concepts you develop or employ

• new approaches or technologies you use

• new tools or technologies

You must explain how you would handle any intellectual property (IP) issues which might arise during the project.

If you are working with subcontractors (specialist skills only), include details of how you will maintain freedom to operate and fulfil the IP requirements detailed in the contract.

This question will be scored against these assessment criteria: How innovative is this project? How much does the project develop or employ novel concepts, approaches, methodologies, tools or technologies for this area?

Question 10. Project plan and methodology

Describe your project plan and identify the main milestones.

The plan for this phase 1 must be comprehensive. The emphasis throughout should be on practicality.

Provide evidence that the technology works, can be made into a viable product and can achieve the proposed benefits.

You must:

• describe resources that will be needed to deliver the project

• describe what the main success criteria will be

• identify the project management processes that will ensure you achieve the milestones

• provide a clear plan for establishing technical and commercial feasibility

• describe the main technical, commercial and environmental risks and what you will do to mitigate them

• provide a clear plan for development of a working prototype

You must upload a project plan or Gantt chart as an appendix in PDF format. It must be a PDF no larger than 10MB. It can be up to two A4 pages and must be legible at 100% zoom.

Your milestones must:

• be clear

• be defined using SMART (specific, measurable, achievable, realistic and time-bound) criteria

• be associated with the appropriate deliverables and payments

• indicate your payment schedule by month

This question will be assessed against these assessment criteria:

• does the proposal show a clear plan for establishing technical and commercial feasibility

• is there a clear management plan

• what are the main technical, commercial, and environmental risks to the project’s success

• how will these be effectively managed

• are the milestones and evaluation procedures appropriate

Note, information from the finances section will be used to support the assessment of this question. Proposed milestones and associated payments stated in this section must match those entered in the finance summary on your application.

Question 11. Technical team and expertise

Who is in the technical team? What expertise do they offer?

Provide a brief description of your technical team, including any subcontractors.

Describe:

• how each organisation has the skills, capabilities, and experience to deliver the intended benefits

• how much of their time will be spent on the project

This question will be scored against this assessment criterion: Does the applicant have the skills, capabilities and experience to deliver the intended benefits?

Question 12. Costs and value for money

How much will the project cost for phase 1? How does it represent value for money for the team and the taxpayer?

Describe:

• the total costs inclusive of VAT (If applicable) you are requesting in terms of the project goals for phase 1

• how this project represents value for money for you and the taxpayer

Proposed costs stated in this section for phase 1 must match those entered in the finance summary. All costs quoted must reflect actual costs at a fair market value and not include profit.

You can submit a single appendix as a spreadsheet in PDF format. It must be a PDF no larger than 10MB. It can be up to two A4 pages and must be legible at 100% zoom.

Indicate your potential costs for phase 2. Progression to phase 2 depends on your success in phase 1.

Note that all payments are made monthly in arrears on submission of an invoice. The invoice must be submitted within 30 days of the end of each monitoring period for all completed milestones.

Full Economic Cost (FEC) calculations are not relevant for Contracts for Innovation competitions. Contracts for Innovation is a competitive process and applications will come from a variety of organisations. Whatever calculation you use to arrive at your total eligible project costs your application will be assessed against applications from other organisations. Bear this in mind when calculating your total eligible project costs. You can include overheads but remember that this is a competitive process.

The assessors are required to judge the application finances in terms of value for money. They will score your finances against this assessment criterion: ‘Are the budget and costs realistic, justified and appropriate for the aims and methods?

Note, the information from the finances section will be used to support the assessment of this question.

Question 13. Commercial potential

What is the commercial potential of your project? You must focus on your proposed customer’s needs.

Describe your:

• timescales

• projects commercial potential for a marketable product, process or service

• delivery plan

• expected route to market

Describe the competitive advantage that your project has over existing or alternative technologies that meet market needs.

Describe any existing commercial relationships relevant to the project.

With the focus on your proposed customer’s needs, you can also mention the future commercial potential across the public or private sector and international markets.

This question will be scored against these assessment criteria:

• is there a clear commercial potential for a marketable product, process or service

• is there a clear plan to deliver that and a clear route to market

• how significant is the competitive advantage of this technology over the nearest currently available solutions to the challenge identified

3. Finances

Enter your phase 1 project costs, organisation details and funding details.

You must select whether you are VAT registered before entering your eligible project costs. We advise you answer the VAT registered question first before entering your eligible costs. Your total eligible project costs must not exceed £200,000.

If you select you are VAT registered, you must enter your eligible project costs exclusive of VAT. As part of the application process VAT will be automatically calculated and added to your eligible project cost total.

If you select you are not VAT registered, you must enter your eligible project costs exclusive of VAT and no VAT will be added. You will not be able to increase total project costs to cover VAT later should you become VAT registered.

VAT is the responsibility of the invoicing business. We will not provide any further advice and advise you to seek independent advice from HMRC.

All milestones must have clear deliverables and success criteria. Evidence that these have been achieved must be provided at each monthly review meeting. The costs for your milestones should be representative of the level of effort required to complete each milestone.

We will not make any advance payments, so you should consider how you will manage your cashflow throughout the life of the project. Agreed milestones will form part of your contract and will be used to monitor the progress of the project.

Full Economic Cost (FEC) calculations are not relevant for Contracts for Innovation competitions. Contracts for Innovation is a competitive process and applications will come from a variety of organisations.

Whatever calculation you use to arrive at your total eligible project costs your application will be assessed against applications from other organisations. Bear this in mind when calculating your total eligible project costs. You can include overheads but remember that this is a competitive process.

For an overview on what costs you can claim, see our project costs guidance. Note this is general guidance, for specific guidance see the eligibility section in this competition.

4. Project Impact

This section is not scored but will provide background to your project.

You must complete the Project Impact questions before being able to submit the application.

More information can be found in our Project Impact guidance and by viewing our Impact Management Framework video.

Innovate UK complies with the requirements of UK GDPR and the Data Protection Act 2018, and is committed to upholding data protection legislation, and protecting your information in accordance with data protection principles.

Assessment

Your application will be reviewed by three independent assessors based on the content of your application and their skills or expertise relevant to your project. All of the scores awarded will count towards the total score used to make the funding decision unless you are notified otherwise.

You can find out more about our assessment process in the General Guidance.

Your submitted application will be assessed against these criteria:

Contracts for Innovation industrial human relevant drug models - Assessor scoring guidance for applicants.pdf (opens in a new window)

Background and further information

About Contracts for Innovation competitions

Contracts for Innovation provides innovative solutions to challenges faced by the public sector. This can lead to better public services and improved efficiency and effectiveness.

The Contracts for Innovation programme:

• supports economic growth and enables the development of innovative products and services through the public procurement of R&D

• generates new business opportunities for companies

• provides a route to market for new ideas

• creates opportunities to work directly with the public sector

Contracts for Innovation competitions are open to all eligible organisations that can demonstrate a route to market for their solution. Developments are 100% funded and focused on specific identified needs, increasing the chance of exploitation.

Contracts for Innovation encourages the creation and protection of new intellectual property (IP). Applicants retain all the rights to both foreground and background IP but will be expected to grant certain royalty-free licences to the funder for use of the foreground IP.

Contracts for Innovation is a procurement of R&D services. If successful, you will receive a contract to deliver the proposed activity. Costs quoted must reflect actual costs at a fair market value and not include profit.

You will be asked to input your milestones with monthly completion dates as part of your application, but payments will only be made monthly and in arrears for completed milestones. This is in line with standard Innovate UK monitoring.

You must submit invoices for all work undertaken and these must be submitted within 30 days of the end of each monthly monitoring period for all completed milestones. Any invoices submitted outside of this time may not be paid until the end of the next monitoring period.

You should consider how this may affect your cash flow throughout the project and what impact this could have on your subcontractors.

If you are VAT registered, your total costs are expected to include VAT that you would charge as a service provider. VAT is the responsibility of the invoicing business and applicants should ensure that VAT has been calculated correctly as part of their application. You will need to confirm your VAT status as part of the application process

Note: we are seeing a rise in double counting of VAT during the application process, making some applicants ineligible. To avoid this, it is important you input your costs minus VAT. VAT is added on by us in the Innovation Funding Service (IFS).

Suppliers for each project will be selected by an open competition process and retain the intellectual property generated from the project, with certain rights of use retained by the contracting authority. This is an excellent opportunity to establish an early customer for a new technology and to fund its development.

Briefing recording and slides

Briefing recording and slides will be available to download here after the briefing event.

Setting up your project

You will be notified by email on the date published for this competition. Notifications may be sent any time up to 5pm.

You must follow the unique link embedded in your email notification. This takes you to your Innovation Funding Service (IFS) Set Up portal, where we gather the information to set up your project.

You will have 30 days (including weekends and bank holidays) to complete all of your project set up. Within this time, you will also be required to submit:

• project location

• any answers to financial or milestone queries we have requested

• any requested documentation to support your project

Your funding offer may be withdrawn if project setup is not completed within this or an alternative timeframe as advised by Innovate UK.

In order for us to process your invoices, you must make sure you have a valid business bank account. It can take several weeks for a new account to be created if required. We recommend starting this process as early as possible to avoid any delays to your project start date.

The bank account which milestone payments are to be paid into must:

• be a business account in the same name as the organisation listed in IFS

• have a cheque and credit clearing facility

Online accounts are eligible as long as they meet the above criteria. UK bank accounts must be regulated by the Prudential Regulation Authority (PRA). International bank accounts may be subject to additional financial checks.

Your Contract

Once you have successfully completed project setup, we will issue your contract. The contract will be made available on your IFS portal. You will need to sign and upload this for us to approve. The contract is final and the terms are non-negotiable. Once approved we will send you an email with permission to start your project on your confirmed start date.

You must not start your project before the date stated on your email and contract. Any costs incurred before your agreed start date cannot be claimed as part of your project.

Your contract start date is provided in the dates and eligibility sections. This cannot be varied and all contracts must start on that date.

If your application is unsuccessful

If you are unsuccessful with your application this time, you can view feedback from the assessors. This will be available to you on your IFS portal following notification.

Sometimes your application will have scored well, and you will receive positive comments from the assessors. You may be unsuccessful as your average score was not above the funding threshold or your project has not been selected under the portfolio approach if this is applied for this competition.

Support for SMEs from Innovate UK Business Growth service

Innovate UK Business Growth helps innovation focused businesses make the best strategic choices and access the right resources, in order to grow and ultimately achieve scale.

Our innovation and growth specialists provide our fully funded and bespoke support to Innovate UK competition winners. Visit the service’s website to learn about how you might benefit as a winner.

Data sharing

This competition is jointly operated by Innovate UK and National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3R) (each an ‘agency’).

Any relevant information submitted and produced during the application process concerning your application can be shared by one agency with the other, for its individual storage, processing and use.

This means that any information given to or generated by Innovate UK in respect of your application may be passed on to NC3R and vice versa. This would include, but is not restricted to:

• the information stated on the application, including the personal details of all applicants

• scoring and feedback on the application

• information received during the management and administration of the contract, such as Monitoring Service Provider reports

Innovate UK may also share any relevant information submitted and produced during the application process concerning your application with Innovate UK’s national and regional UK third parties and partners who may contact you. For more information see how we handle grant applicant and grant holder data.

Innovate UK and NC3R are directly accountable to you for their holding and processing of your information, including any personal data and confidential information. Data is held in accordance with their own policies. Accordingly, Innovate UK, Innovate UK Business Connect and NC3R will be data controllers for personal data submitted during the application.

Innovate UK’s Privacy Policy

Innovate UK Business Connect Privacy Policy

NC3R Privacy Policy

Innovate UK complies with the requirements of UK GDPR and the Data Protection Act 2018, and is committed to upholding data protection legislation, and protecting your information in accordance with data protection principles.

The Information Commissioner’s Office also has a useful guide for organisations, which outlines the data protection principles.

Further help and guidance

If you want help to find an organisation to work with, contact the Innovate UK Business Connect.

If you have any questions about the scope requirements of this competition, email support@iuk.ukri.org .

If you need more information about how to apply or you want to submit your application in Welsh, email support@iuk.ukri.org or call 0300 321 4357.

Our phone lines are open from 9am to 12pm and 2pm to 5pm UK time, Monday to Friday (excluding bank holidays).

Innovate UK or any of our partners will not tolerate abusive language in any written or verbal correspondence, applications, social media or any other form that might affect staff.